SOURCE: Endo Pharmaceuticals

October 13, 2008 16:30 ET

Endo Pharmaceuticals to Hold Conference Call and Webcast on Third Quarter 2008 Financial Results

CHADDS FORD, PA--(Marketwire - October 13, 2008) - Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) will announce its third quarter financial results on October 30, and will hold a conference call at 10:00 a.m. ET that day to discuss these results.

David P. Holveck, President and Chief Executive Officer, Nancy J. Wysenski, Chief Operating Officer, and Blaine Davis, Vice President, Corporate Affairs will host the call.

Investors and other interested parties may call 800-591-6930 (domestic) or 617-614-4908 (international) and enter code 75851962. Please dial in 10 minutes prior to the scheduled start time.

A replay of the call will be available from October 30 at 1:00 p.m. ET until 12:00 a.m. ET on November 6 by dialing 888-286-8010 (domestic) or 617-801-6888 (international), passcode 83201262.

A simultaneous webcast of the call may be accessed by visiting www.endo.com. In addition, a replay of the webcast will be available until 12:00 a.m. ET on November 6. The replay can be accessed by clicking on "Events" in the Investor Relations section of the website.

About Endo

Endo Pharmaceuticals is a specialty pharmaceutical company with a broad portfolio of branded and generic prescription products focused on providing relief from pain. Endo is dedicated to improving the lives of patients through identifying, developing, and marketing innovative and differentiated products in pain management and related therapeutic areas. More information, including this and past press releases about Endo Pharmaceuticals Holdings Inc., is available at www.endo.com.

Contact Information

  • CONTACT:
    Blaine Davis
    (610) 459-7158